The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

The FDA approved neoadjuvant durvalumab with gemcitabine and cisplatin, followed by adjuvant durvalumab, for muscle invasive bladder cancer (MIBC). Phase 3 NIAGARA trial results showed improved ...

Exercise could potentially reduce the recurrence rate of breast cancer, new research from Edith Cowan University (ECU) has ...

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer.

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

This approval of durvalumab marks the first and only perioperative immunotherapy regimen available in muscle-invasive bladder ...

Magnesium is essential for muscle, nerve function, blood sugar control, and energy production. Deficiency symptoms can be ...

Research on atherosclerosis, a disease known for plaques that damage and block blood vessels, finds that some smooth muscle changes in the lining of vessels are similar to those that occur with cancer ...

The FDA has approved neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab after radical cystectomy in MIBC.